Director, Health Economics and Outcomes Research

Summary

Join Corcept Therapeutics as their Director of Health Economics and Outcomes Research (HEOR), focusing on Oncology. You will spearhead the development and implementation of Value Dossiers for oncology products, lead systematic literature reviews, and create cost-effectiveness models. This role requires managing indirect treatment comparisons, real-world evidence studies, and HTA dossier development. You will collaborate with cross-functional teams, present HEOR evidence to stakeholders, and drive innovation within HEOR. The position reports to the Senior Director of HEOR and involves working cross-functionally with Medical Affairs, Market Access, and Clinical Development. The ideal candidate will play an integral role in the launch and commercialization activities of Corcept's oncology portfolio globally.

Requirements

Applicants must be currently authorized to work in the United States on a full-time basis

Responsibilities

• Spearhead the development and strategic implementation of Value Dossiers (AMCP & global value dossiers) for oncology products, ensuring alignment with clinical, scientific, and economic data to support market access and reimbursement negotiations in the US and global markets
• Lead and oversee the design and execution of systematic literature reviews to generate high-quality evidence that informs health economic models, HTA submissions, and reimbursement strategies. Establish rigorous methodologies for literature search, inclusion/exclusion criteria, and data extraction, ensuring robust evidence synthesis to support strategic decision-making
• Develop, adapt, and oversee the creation of cost-effectiveness models and budget impact models for oncology therapies. Collaborate with internal stakeholders to ensure alignment with global pricing and market access strategies
• Manage and lead the execution of indirect treatment comparison studies to assess the relative efficacy of oncology therapies in comparison to competing products or alternative treatment options
• Design, execute, and oversee real-world observational studies (e.g., registries, retrospective studies) to assess the long-term outcomes, effectiveness, and safety of oncology therapies in routine clinical practice
• Support the preparation of HTA submissions for oncology products, ensuring all the evidence needs are adequately captured for the key EU markets. Collaborate with cross-functional teams to ensure optimal evidence generation for reimbursement
• Drive innovation within HEOR by identifying emerging methodologies and best practices in health economics, epidemiology, and outcomes research. Lead the development of novel models, frameworks, and tools that enhance the understanding of oncology therapy value. Serve as a key scientific leader, representing the company in external engagements, conferences, and industry forums
• Act as a strategic partner to clinical development, regulatory affairs, commercial, and medical affairs teams, ensuring HEOR insights are seamlessly integrated into global and local market access strategies
• Develop and present HEOR evidence to internal executives, external stakeholders, payers, and HTA bodies to drive alignment on the value proposition of oncology therapies. Establish and maintain strong relationships with key decision-makers in the healthcare ecosystem
• Demonstrate strong leadership in cross-functional and cross-regional teams, fostering a high-performance culture and influencing senior stakeholders with data-driven insights
• Uphold Corcept’s Key Principles by driving collaboration, embracing possibilities, following the data, and leading by doing, ensuring all initiatives align with the Company’s ethics and patient-first principles

Preferred Qualifications

• Proficiency in advanced statistical and modeling techniques for economic evaluation (e.g., Markov models, decision trees, cohort simulations)
• In-depth knowledge and ability to apply knowledge of US and global healthcare systems, global HTA requirements, and clinical development, to identify evidence gaps and formulate evidence generation and communication strategies
• Expertise in the preparation and delivery of high-quality, evidence-based health economic reports and presentations to stakeholders at various levels
• Generate peer-reviewed publications to communicate study findings in scientific channels in alignment with the product publication strategy and the overall HEOR evidence generation strategy
• Strong project management skills, with the ability to manage multiple priorities and deadlines
• Advanced degree (PhD, MSc, or equivalent) in health economics, public health, health policy, statistics, or a related field. A focus on oncology is highly desirable
• At least 5-10 years of experience in HEOR, with a strong background in oncology
• Proven experience developing cost-effectiveness models, budget impact models, and global value dossiers for oncology products
• Demonstrated expertise in indirect treatment comparisons, real-world evidence generation, and observational study designs (e.g., registries)
• Proficiency in English is required

Benefits

• 10 % with travel as required
• #LI-Remote
• The pay range that the Company reasonably expects to pay for this position is £130,000 – £150,000 per annum